Steve Aselage, Director at Acer Therapeutics Inc. (ACER), bought 819,672 shares at $1.22 ($1000K) on 2022-11-29, disclosed to the SEC on 2022-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 409,836 | $500K | 50.0% |
| 2 | $1.22 | 409,836 | $500K | 50.0% |
| Total | $1.22 avg | 819,672 | $1000K | 100% |
| Filing → |
| ACER | BUY | 2021-12-13 | $21K | — | Filing → |
| TVTX | SELL | 2021-11-18 | $935K | — | Filing → |
| TVTX | SELL | 2021-11-09 | $262K | — | Filing → |